Skip to main content
SpringerLink
Log in

Does high sensitivity troponin add prognostic value to validated risk scores to predict in-hospital mortality in patients with acute heart failure?

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Troponin elevation correlates with an increased short and long-term mortality in patients with acute decompensated heart failure (AHF). However, it has not been included in the development of multiple validated predictive models of mortality. We aim to  determine whether the addition of high-sensitivity troponin T (hs-TnT) to clinical risk scores improves the prediction of in-hospital mortality in patients with AHF. A retrospective analysis of a prospective and consecutive cohort was performed. Adult patients hospitalized between 2015 and 2019 with a primary diagnosis of AHF were included. Hs-TnT was measured on admission. OPTIMIZE-HF, GWTG-HF, and ADHERE risks score were calculated for each patient. The primary endpoint was all-cause in-hospital mortality. Discrimination of isolated hs-TnT and the risk scores with and without the addition of hs-TnT were evaluated using the area under the ROC curve (AUC-ROC). A subanalysis was performed according to left ventricular ejection fraction (LVEF). Of 712 patients, 562 (79%) had hs-TnT measurement upon admission, and was elevated in 91%. In-hospital mortality was 8.7% (n = 49). The AUC-ROC was 0.70 (95% CI 0.63–0.77) for isolated hs-TnT, and 0.80 (0.74–0.87), 0.79 (0.72 -0.86) and 0.79 (0.71–0.86) for the OPTIMIZE-HF, GWTG-HF and ADHERE scores, respectively. The addition of hs-TnT to the models did not increase the AUC: 0.72 (0.66–0.79) for the OPTIMIZE-HF + hs-TnT score (difference between AUC − 0.08 p = 0.04), 0.74 (0.68–0.80) for GWTG-HF (difference between AUC-0.04, p = 0.2) and 0.7 (0.63–0.77) for ADHERE (difference between AUC − 0.085 p = 0.07). The models presented good calibration (p > 0.05). In the sub-analysis, no differences were found between risk scores with the addition of hs-TnT in the population with LVEF < 40% and ≥ 40%. Elevated hs-TnT on admission was frequent and its incorporation into the validated risk scores did not prove an incremental prognostic benefit in patients hospitalized for AHF, regardless of LVEF. Isolated hs-TnT had a modest ability to predict hospital mortality. Additional prospective studies are needed to validate these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bui AL, Horwich TB (2011) Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41

    Article  Google Scholar 

  2. Metra M, Teerlink JR (2017) Heart failure. Lancet 390:1981–1995

    Article  Google Scholar 

  3. Ketchum ES, Levy WC (2011) Establishing prognosis in heart failure: a multimarker approach. Prog Cardiovasc Dis 54:86–96

    Article  Google Scholar 

  4. Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, Cook NR, Felker GM, Francis GS, Hauptman PJ, Havranek EP, Krumholz HM, Mancini D, Riegel B, Spertus JA , American Heart Association; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia. (2012). Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation 125(1928):1952

    Google Scholar 

  5. Passantino A, Monitillo F, Iacoviello M, Scrutinio D (2015) Predicting mortality in patients with acute heart failure: Role of risk scores. World J Cardiol 7:902–911

    Article  Google Scholar 

  6. Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, Greenberg BH, Filippatos G, Davison BA, Cotter G, Prescott MF, Hua TA, Lopez-Pintado S, Severin T, Metra M (2015) Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail 17:1262–1270

    Article  CAS  Google Scholar 

  7. You JJ, Austin PC, Alter DA, Ko DT, Tu JV (2007) Relation between cardiac troponin I and mortality in acute decompensated heart failure. Am Heart J 153:462–470

    Article  CAS  Google Scholar 

  8. Diez M, Talavera ML, Conde DG, Campos R, Acosta A, Trivi MS (2016) High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure. Cardiol J. 23(78):83

    Google Scholar 

  9. Fonarow GC, Peacock WF, Horwich TB, Phillips CO, Givertz MM, Lopatin M, Lopatin M, Wynne J (2008) Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 101:231–237

    Article  CAS  Google Scholar 

  10. Ilva T, Lassus J, Siirila-Waris K, Melin J, Peuhkurinen K, Pulkki K, Nieminen MS, Mustonen H, Porela P, Harjola VP (2008) Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 10:772–779

    Article  CAS  Google Scholar 

  11. Peacock WF 4th, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Apple FS, Wu HB (2008) Cardiac troponin and outcome in acute heart failure. N Engl J Med 358:2117–2126

    Article  CAS  Google Scholar 

  12. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB (2008) Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 52:347–356

    Article  Google Scholar 

  13. Al-Saleh A, Alazzoni A, Al Shalash S, Ye C, Mbuagbaw L, Thabane L, Jolly SS (2014) Performance of the high-sensitivity troponin assay in diagnosing acute myocardial infarction: systematic review and meta-analysis. CMAJ Open 2:E199-207

    Article  Google Scholar 

  14. Velilla Moliner J, Gros Bañeres B, Povar Marco J, Santaló Bel M, Ordoñez Llanos J, Martín Martín A, Ruize FT (2020) Diagnostic performance of high sensitive troponin in non-ST elevation acute coronary syndrome. Med Intensiva 44:88–95

    Article  CAS  Google Scholar 

  15. Fitzgerald RL, Hollander JE, Peacock WF, Limkakeng AT, Breitenbeck N, Blechschmidt K, Laimighofer M, DeFilippi C (2019) Analytical performance evaluation of the Elecsys® Troponin T Gen 5 STAT assay. Clin Chim Acta 495:522–528

    Article  CAS  Google Scholar 

  16. Parissis JT, Papadakis J, Kadoglou NP, Varounis C, Psarogiannakopoulos P, Rafouli-Stergiou P, Ikonomidis I, Paraskevaidis I, Dimopoulou I, Zerva A, Dima K, Anastasiou-Nana M, Filippatos G (2013) Prognostic value of high sensitivity troponin T in patients with acutely decompensated heart failure and non-detectable conventional troponin T levels. Int J Cardiol 168:3609–3612

    Article  Google Scholar 

  17. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147-239

    Article  Google Scholar 

  18. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ, ADHERE Scientific Advisory Committee, Study Group, and Investigators (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293(572):580

    Google Scholar 

  19. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB (2008) Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 52:347–356

    Article  Google Scholar 

  20. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA (2010) A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes 3:25–32

    Article  Google Scholar 

  21. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA (2010) Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56:254–261

    Article  CAS  Google Scholar 

  22. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172

    Article  Google Scholar 

  23. Pocock SJ, Ariti CA, McMurray JJV, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 34:1404–1413

    Article  Google Scholar 

  24. Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, Woodward M, Patel A, McMurray J, MacMahon S (2014) Risk prediction in patients with heart failure. JACC Heart Fail 2:440–446

    Article  Google Scholar 

  25. Ouwerkerk W, Voors AA, Zwinderman AH (2014) Factors influencing the predictive power of models for predicting mortality and/or heart-failure hospitalization in patients with heart failure. JACC Heart Fail 2:429–436

    Article  Google Scholar 

  26. Lupón J, de Antonio M, Vila J, Peñafiel J, Galán A, Zamora E, Urrutia A, Bayes-Genis A (2014) Development of a novel heart failure risk tool: the Barcelona bio-heart failure risk calculator (BCN bio-HF calculator). PLoS ONE 9:e85466

    Article  Google Scholar 

  27. Levy WC (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424–1433

    Article  Google Scholar 

  28. Mozaffarian D, Anker SD, Anand I, Linker DT, Sullivan MD, Cleland JGF, Carson PE, Maggioni AP, Mann DL, Pitt B, Poole-Wilson PA, Levy WC (2007) Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation 116:392–398

    Article  Google Scholar 

  29. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV (2003) Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290:2581–2587

    Article  CAS  Google Scholar 

  30. O’Connor CM, Hasselblad V, Mehta RH, Tasissa G, Califf RM, Fiuzat M, Rogers JG, Leier CV, Stevenson LW (2010) Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. J Am Coll Cardiol 55:872–878

    Article  Google Scholar 

  31. Xue Y, Clopton P, Peacock WF, Maisel AS (2011) Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail 13:37–42

    Article  CAS  Google Scholar 

  32. Pascual-Figal DA, Manzano-Fernandez S, Boronat M, Casas T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdés M, Januzzi JL (2011) Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 13:718–725

    Article  CAS  Google Scholar 

  33. Meigher S, Thode HC, Peacock WF, Bock JL, Gruberg L, Singer AJ (2016) Causes of elevated cardiac troponins in the emergency department and their associated mortality. Acad Emerg Med 23:1267–1273

    Article  Google Scholar 

  34. Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie BM, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O’Connor CM (2012) Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail 14:1257–1264

    Article  CAS  Google Scholar 

  35. Metra M, Bettari L, Pagani F, Lazzarini V, Lombardi C, Carubelli V, Bonetti G, Bugatti S, Parrinello G, Caimi L, Felker GM, Dei Cas L (2012) Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation. Clin Res Cardiol 101:663–672

    Article  CAS  Google Scholar 

  36. Pang PS, Fermann GJ, Hunter BR, Levy PD, Lane KA, Li X, Cole M, Collins SP (2019) TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial). Circ Heart Fail 12:e005931

    Article  CAS  Google Scholar 

  37. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Group ESCSD (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J. 40(237):269

    Google Scholar 

  38. - Roset A, Jacob J, Herrero-Puente P, Alquézar A, Martín-Sanchez FJ, Llorens P, Gil V, Cabello I , Richard F, Garrido JM, Gil C, Llauger L, Wussler D, Mueller C, Miró O; ICA-SEMES Research Group (2020). High-sensitivity cardiac troponin T 30 days all-come mortality in patients with acute heart failure. A Propensity Score-Matching Analysis Based on the EAHFE Registry. TROPICA4 Study. Eur J Clin Invest 50:e13248.

Download references

Funding

No funding sources

Author information

Authors and Affiliations

  1. Heart Failure, Pulmonary Hypertension and Transplant, Instituto Cardiovascular de Buenos Aires. Av. del Libertador, 6302, CP 1428, Ciudad de Buenos Aires, Argentina

    Lucrecia M. Burgos, Lujan Talavera & Mirta Diez

  2. Clinical Cardiology Department, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina

    Rita M. Miranda, Lorena Villalba & Andreina Gil Ramirez

  3. Research Department, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina

    Fernando Botto

Authors
  1. Lucrecia M. Burgos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rita M. Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorena Villalba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andreina Gil Ramirez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lujan Talavera
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernando Botto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mirta Diez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lucrecia M. Burgos.

Ethics declarations

Conflict of interests

Nothing to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 19 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Burgos, L.M., Miranda, R.M., Villalba, L. et al. Does high sensitivity troponin add prognostic value to validated risk scores to predict in-hospital mortality in patients with acute heart failure?. Heart Vessels 36, 1679–1687 (2021). https://doi.org/10.1007/s00380-021-01847-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-021-01847-6

Keywords

Search

Navigation